Senolytic therapy in Alzheimer’s disease: clinical evidence and biomarkers
Background: Alzheimer’s disease is a progressive neurodegenerative disorder in which cellular senescence and a pro-inflammatory environment influence its natural course. Senolytic therapy has emerged as a potential strategy by proposing the elimination of these cells, with the potential to modulate disease progression....